Generation of pediatric liver cancer patient–derived xenograft platforms for pediatric liver cancer: A critical stage in the development of anticancer treatments

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|64|4|1017-1019

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.64, Iss.4, 2016-10, pp. : 1017-1019

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1121-1135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?

By Jin Ketao   He Kuifeng   Li Guangliang   Teng Lisong  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 597-606

Future Medicine

Access to resources Recommend Favorite

Next generation sequencing in pediatric hepatology and liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 24, Iss. 2, 2018-02 ,pp. : 282-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pediatric patient with end‐stage kidney disease secondary to Eagle‐Barrett syndrome and metastatic unresectable hepatoblastoma treated successfully with chemotherapy and liver‐kidney transplant

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Caval agenesis in the pediatric liver donor

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : E139-E141

John Wiley & Sons Inc

Access to resources Recommend Favorite